Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/10
End: 11/30/11
Due: 11/30/12
Phase: N/A
Priority: Normal
Start: 02/28/14
End: 09/30/15
Due: 09/30/16
Phase: N/A
Priority: Normal
Start: 01/01/22
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 10/01/21
End: 09/30/24
Due: 09/30/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Differential Diagnosis of STA-PSV in Thyrotoxicosis | NCT01227499 | xiaolong zhao | user2@example.com | None | 2010-06-30 | 2011-11-30 | 2012-11-30 | - | - | 2025-07-14 |
| Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy | NCT02129985 | xiaolong zhao | user2@example.com | None | 2014-02-28 | 2015-09-30 | 2016-09-30 | - | - | 2025-07-14 |
| Intervention Effect of Canagliflozin on Prediabetes in Patients With HIV. | NCT05135039 | xiaolong zhao | user2@example.com | None | 2022-01-01 | 2024-12-31 | 2025-12-31 | - | - | 2025-07-14 |
| Insulin Dose Calculation Software in Insulin Therapy | NCT05389839 | xiaolong zhao | user2@example.com | None | 2021-10-01 | 2024-09-30 | 2025-09-30 | - | - | 2025-07-14 |